The # and pace of share sales depend on share price ceterus paribus. I think the company intends to move forward with B-UC regardless. And it sounds like they're expecting a deal on B-OM soon.
Desire to learn -Partnership for "K' is many years away. When a company gets into cancer research it could drag on for many years. Those 300 million shares will disappear in the blink of an eye.